Nature's Miracle Holding Inc. Reports Director/Officer Changes
Ticker: NMHIW · Form: 8-K · Filed: Dec 5, 2024 · CIK: 1947861
Sentiment: neutral
Topics: leadership-change, officer-appointment, director-election, filing-update
Related Tickers: NMHI
TL;DR
NMHI board shakeup, new execs appointed, check the filings.
AI Summary
Nature's Miracle Holding Inc. (NMHI) filed an 8-K on December 5, 2024, reporting events as of December 1, 2024. The filing indicates changes related to the departure and election of directors, appointment of officers, and compensatory arrangements. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
Changes in a company's board of directors and executive officers can signal shifts in strategy, governance, or operational focus.
Risk Assessment
Risk Level: medium — Changes in leadership and executive compensation can introduce uncertainty and impact future company performance.
Key Numbers
- 1231 — Fiscal Year End (Indicates the end of the company's financial reporting year.)
- 20241201 — Report Date (The earliest event date reported in the filing.)
Key Players & Entities
- Nature's Miracle Holding Inc. (company) — Registrant
- LBBB Merger Corp. (company) — Former Company Name
- 001-41977 (company) — SEC File Number
- 88-3986430 (company) — IRS Number
FAQ
What specific changes occurred regarding directors and officers?
The filing indicates the departure of directors, election of new directors, and appointment of certain officers, along with details on compensatory arrangements.
When were these changes effective?
The earliest event reported is as of December 1, 2024.
What is the company's primary business sector?
The company is classified under FARM MACHINERY & EQUIPMENT [3523].
What is the company's SEC file number?
The SEC file number is 001-41977.
What was the company's former name?
The company's former name was LBBB Merger Corp., with a name change date of September 22, 2022.
Filing Stats: 1,164 words · 5 min read · ~4 pages · Grade level 10.1 · Accepted 2024-12-05 16:10:24
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share NMHI The Nasdaq Stock Mar
- $11.50 — e Common Stock, at an exercise price of $11.50 per share NMHIW The Nasdaq Stock Ma
- $280,000 — Huang will receive an annual salary of $280,000 and a one-time equity grant of 100,000
Filing Documents
- ea0223714-8k_natures.htm (8-K) — 37KB
- ea022371401ex10-1_natures.htm (EX-10.1) — 57KB
- ea022371401ex99-1_natures.htm (EX-99.1) — 15KB
- 0001213900-24-106052.txt ( ) — 346KB
- nmhi-20241201.xsd (EX-101.SCH) — 4KB
- nmhi-20241201_def.xml (EX-101.DEF) — 26KB
- nmhi-20241201_lab.xml (EX-101.LAB) — 36KB
- nmhi-20241201_pre.xml (EX-101.PRE) — 25KB
- ea0223714-8k_natures_htm.xml (XML) — 6KB
02 Departure of Directors or Certain
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of George Yutuc as Chief Financial Officer and Appointment as Chief Operating Officer On December 1, 2024, the Board of Directors (the "Board") of Nature's Miracle Holding Inc. (the "Company") approved the transition of George Yutuc from his role as Chief Financial Officer to Chief Operating Officer of the Company, effective immediately. Appointment of Daphne Y. Huang as Chief Financial Officer On December 1, 2024, the Board appointed Daphne Y. Huang, effective December 1, 2024, as Chief Financial Officer of the Company. Prior to her appointment as Chief Financial Officer of the Company, Ms. Huang, 54 years old, served as Chief Financial Officer at Gorilla Technology Group Inc., a Nasdaq-listed company providing global Edge AI security solutions, from July 2022 to August 2024. From August 2021 to July 2022, she was the Chief Financial Officer of GoFor Industries Inc., an IT platform enabled last mile logistics company operating in Canada and the United States. Between April 2020 and August 2021, Ms. Huang served as Chief Financial Officer and Chief Accounting Officer at Taro Pharmaceutical Industries Ltd., a multinational pharmaceutical company listed on NYSE. Prior to that, she held the role of Chief Financial Officer and Interim Chief Operating Officer at Humanwell USA LLC / PuraCap International LLC, a global pharmaceutical company, from June 2016 to April 2020. Earlier in her career, Ms. Huang served as a Senior Portfolio Manager in the Middle Market Banking Group at HSBC Bank from 2015 to 2016. From 2009 to 2015, she was the Chief Financial Officer at Lihua International, Inc., a Nasdaq-listed manufacturing and distribution company. Ms. Huang also held roles in debt capital markets as Vice President at GE Capital Markets, Inc. from 2003 to 2009 and as Senior Associate at Fleet Securities,
01. Regulation FD Disclosures
Item 7.01. Regulation FD Disclosures. On December 3, 2024, the Company issued a press release announcing the appointment of Daphne Y. Huang as the Company's Chief Financial Officer and the appointment of George Yutuc as the Company's Chief Operating Officer. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein. The information in this Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 7.01 shall not be incorporated by reference into any filing with the SEC made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 10.1 Employment Agreement, dated December 1, 2024, by and between Nature's Miracle Holding Inc. and Daphne Y. Huang. 99.1 Press Release of Nature's Miracle Holding Inc. dated December 3, 2024. 104 Cover Page Interactive Data File (formatted in Inline XBRL). 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 5, 2024 NATURE'S MIRACLE HOLDING INC. By: /s/ Tie (James) Li Name: Tie (James) Li Title: Chief Executive Officer 3